Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of the American Chemical Society|June 10, 2025
In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein DegradationYunan Zheng, Anamika Singh, Zeqi Niu, et al.
Journal of Proteome Research|October 3, 2008
Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibitionScott E Warder, Lora A Tucker, Shaun M McLoughlin, et al.
ACS Central Science|December 4, 2025
Proteome-Wide Discovery of Degradable Proteins Using Bifunctional MoleculesInes Forrest, Louis P Conway, Clara Gathmann, et al.
European Biophysics Journal : EBJ|February 17, 2025
A paradigm shift: analytical ultracentrifugation as a multi-attribute platform method in targeted protein degradationAlexander E Yarawsky, Judith A Ronau, Tiffany A Thibaudeau, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidizationO Jameel Shah, Xiaoyu Lin, Leiming Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathwayJeffrey F Waring, Yi Yang, Christine H Healan-Greenberg, et al.
ACS Chemical Biology|July 9, 2024
Quantitative Measurement of Rate of Targeted Protein DegradationThomas L Lynch, Violeta L Marin, Ryan A McClure, et al.
ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.
Cell Chemical Biology|October 7, 2025
Discovery of a tau-aggregate clearing compound that covalently targets P4HBLouis P Conway, Michelle A Estrada, Weichao Li, et al.
Cancer Research|April 19, 2017
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic StrategiesMai H Bui, Xiaoyu Lin, Daniel H Albert, et al.
Pageof 9